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KG-501According to the advocated paradigm shift in toxicology, acquisition of knowledge on the mechanisms underly-
ing the toxicity of chemicals, such as perturbations of biological pathways, is of primary interest. Pluripotent stem
cells (PSCs), such as human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs),
offer a unique opportunity to derive physiologically relevant human cell types to measure molecular and cellular
effects of such pathway modulations. Here we compared the neuronal differentiation propensity of hESCs and
hiPSCswith the aim to develop novel hiPSC-based tools formeasuring pathway perturbation in relation tomolec-
ular and cellular effects in vitro. Among other fundamental pathways, also, the cAMP responsive element binding
protein (CREB) pathway was activated in our neuronal models and gave us the opportunity to study time-
dependent effects elicited by chemical perturbations of the CREB pathway in relation to cellular effects. We
show that the inhibition of the CREB pathway, using 2-naphthol-AS-E-phosphate (KG-501), induced an inhibition
of neurite outgrowth and synaptogenesis, aswell as a decrease ofMAP2+neuronal cells. These data indicate that a
CREB pathway inhibition can be related to molecular and cellular effects that may be relevant for neurotoxicity
testing, and, thus, qualify the use of our hiPSC-derived neuronal model for studying chemical-induced neurotox-
icity resulting from pathway perturbations.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
In the vision and strategy document "Toxicity Testing in the 21st
Century" of the US National Research Council (NRC), a paradigm shift
in regulatory toxicity testing is envisioned from the current testing
approach, relying on phenotypic changes in animals, to an approach
focusing on understanding how chemical-induced perturbations of
biological pathways can lead to toxic effects in humans ((NRC), 2007).
The vision focuses on the identiﬁcation of toxicity pathways, which
are “normal cellular response pathways that are expected to result in
adverse health effects when sufﬁciently perturbed” ((NRC), 2007).
This means that toxicity pathways represent perturbations of biological
pathways that cannot be recovered by adaptive stress responses, which
will lead to cell injury and as a result to morbidity andmortality in vivo.spra (VA), Italy. Fax: +39 0332
remer-Hoffmann).
. This is an open access article underIn the US-EPA screening project ToxCast, high-throughput screenings
have been performed, in which chemicals have been assessed for the
perturbation of key biological pathways (Dix et al., 2007; Judson et al.,
2010). Some of the ToxCast data have already been analyzed to assess
correlations between pathway perturbations and cellular/tissue injury,
particularly in relation to developmental toxicity, impairment of vascu-
lar development and endocrine disruption (Chandler et al., 2011;
Kleinstreuer et al., 2011; Sipes et al., 2011; Rotroff et al., 2013). In addi-
tion, the possible correlation between pathway perturbations and acti-
vation of adaptive stress responses should be taken into account in
order to test whether a certain biological pathway can qualify as a tox-
icity pathway.
In the present study we aim to relate the perturbation of a biological
pathway (the cAMP responsive element binding protein (CREB) path-
way) to cellular effects in relevant human target cells (human induced
pluripotent stem cell (PSC)-derived neuronal cultures).
PSCs are currently seen as a promising cell source for toxicological
applications, as their derivatives exhibit normal, non-pathologicthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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twomajor types of PSC cultures that aremost promising are human em-
bryonic stem cells (hESCs) and human induced pluripotent stem cells
(hiPSCs). Currently, hESCs as well as hiPSCs are widely used in the
area of basic research and regenerative medicine (Drews et al.,
2012; Ho et al., 2012). This expertise can now be harnessed for
their application in in vitro toxicology. However, test methods for
regulatory safety assessment based on hESCs would unlikely be ac-
cepted worldwide, due to diverse national legislative policies regu-
lating the use of embryo-derived cell lines. An alternative to hESC-
based assays might be the use of hiPSC-based assays for regulatory
toxicity testing (Kumar et al., 2012). HiPSCs are commonly derived
from fetal or adult somatic cells but still share similar characteristics
with hESCs (Krueger et al., 2010; Pistollato et al., 2012) and hold a
great potential for in vitro methods, both for identifying therapeutic
targets as well as for safety assessment. Nevertheless, recent publica-
tions demonstrated the existence of some substantial epigenetic dif-
ferences between hESCs and hiPSCs, with hiPSCs showing signiﬁcant
reprogramming variability, including somatic memory and aberrant
reprogramming of DNA methylation, compared to hESCs (Daniels
et al., 2010; Ghosh et al., 2010; Lister et al., 2011). Therefore, it is of
interest to characterize and compare cellular derivatives of both
PSC models in order to determine the suitability of PSC-derivatives
for toxicological applications. Moreover, in light of the novel toxicity
paradigm, these stem cell derivatives can be used to detect perturba-
tions of pathways that may underlie the molecular and cellular
events leading to cell injury. Here we differentiate hiPSCs (IMR90-
hiPSCs) into post-mitotic neurons, comparing their differentiation
efﬁciency to hESCs (H9), with the goal to correlate chemical-
induced perturbations of the neuronal-related CREB pathway to mo-
lecular and cellular events that may play a role in neuronal cell
injury.
The CREB pathway is crucial in the development of the central
nervous system (CNS), including neuronal survival, neurite outgrowth,
precursor proliferation and neuronal differentiation (Lonze and Ginty,
2002). It plays an important role in learning and memory formation,
the entrainment of the circadian clock, as well as in addiction (Lonze
and Ginty, 2002). A wide range of stimuli can activate CREB signaling
in neurons, like hormones, neurotransmitters, growth factors and
Ca2+, but also stress (Shaywitz and Greenberg, 1999; Lonze and Ginty,
2002). CREB has been found altered in several neuronal diseases, like
Huntington disease, the Cofﬁn–Lowry syndrome, the Rubinstein–Taybi
Syndrome and Alzheimer's disease (Saura and Valero, 2011). The rele-
vance of the CREB pathway for the nervous system has also been dem-
onstrated by toxicity studies that have related the perturbation of the
CREB signaling pathway to neurotoxicity (Schuh et al., 2002; Chalovich
et al., 2006; Damodaran et al., 2009; Zuo et al., 2009; Liu et al., 2010;
Xu et al., 2011; Brunelli et al., 2012). Therefore, the CREB pathway is
an interesting pathway to be explored as a toxicity pathway in relation
to neurotoxicant exposure.
In order test effects of CREB pathway perturbationswe used the spe-
ciﬁc CREB signaling inhibitor 2-naphthol-AS-E-phosphate (KG-501),
administered in a time course fashion in our hiPSC-derived neuronal
cultures. KG-501 caused an inhibition of neurite outgrowth and synap-
togenesis and a decrease of MAP2+ neuronal cells. Our data indicate
that our hiPSC-derived neuronal cultures might be useful tools to
study chemical effects on neuronal cells, providing a valuable alterna-
tive to the use of other in vitro cell models, such as cancer cell lines or
animal cells.
Materials and methods
PSC lines and culture conditions. For this study, the H9 hESC cell line
(obtained from WiCell, MTA number: 10-W0409) and the IMR90
hiPSC line (provided by I-Stem, Evry, France) have been used. The H9
line was derived from a supernumerary IVF embryo and the karyotypeis 46,XX, indicative of a normal diploid female (https://www.wicell.
org/index.php?option=com_content&task=view&id=206&Itemid=
0); the IMR90 line was established on 07/07/1975 using explants of
minced lung tissue obtained from a clinically normal 16 week old
fetus. The karyotype is 46,XX, indicative of a normal diploid female
(http://ccr.coriell.org/Sections/Search/Sample_Detail.aspx?Ref=I90-
52&PgId=166). IMR90 cells had been reprogrammed in the laboratories
of I-Stem towards pluripotency by retroviral transduction of Oct4 and
Sox2, using the pMIG vectors (Addgene).
hESC and the hiPSC lines were grown on mitomycin-inactivated
human feeder ﬁbroblasts (hDFn, Gibco, Cascade Biologics), which
have been plated on 0.1% gelatin (Sigma Aldrich) and diluted in 1×
PBS (Gibco, Life Technologies). Cells were grown in 5% ± 1% CO2/
air in humidiﬁed incubators (37 °C ± 1 °C), and medium was
changed every day with the addition of basic FGF (bFGF, Immunolog-
ical Sciences) at the concentration of 8 ng/ml for hESCs and 10 ng/ml
for hiPSCs (Supplementary Tables 1 and 2). PSC colonies were pas-
saged by micro-dissection using a 30G needle and p100 μl tip and re-
growth from small colony fragments on feeder cell layers. Normally,
about 100 fragments were replated, with a plating efﬁciency of about
80%. To assess stem cell pluripotency, we used the common approach
based on “spontaneous” embryoid body (EB) formation, which can
form the three germ layers (Shamblott et al., 2001), followed by qPCR
analyses of germ layer speciﬁc genes. Regular checking for potential
mycoplasma contamination has been performed twice per month and
before preparing frozen cell stocks by doing qPCR on an ABI PRISM®
7000 Sequence Detection System (Applied Biosystems) with a speciﬁc
mycoplasma detection kit (Minerva Biolabs) on both cell supernatants
and cell samples.
Differentiation protocol for post-mitotic neurons and time course treat-
ment with 2-naphthol-AS-E-phosphate (KG-501). H9 and IMR90 cells
were differentiated into post-mitotic neurons, as previously described
(Stummann et al., 2009), with some modiﬁcations. Brieﬂy, EBs were
generated by detaching undifferentiated colonies by manual cutting of
colonies into 200 μm × 200 μm fragments. Floating EBs were cultured
for 1 day in the presence of complete hESC or hiPSC medium (Supple-
mentary Tables 1 and 2) without bFGF. Then, on day 2, EBs were plated
on laminin coated dishes (1 mg/ml stock, Sigma L2020, used at ﬁnal
concentration of 10 μg/ml in sterile mqwater) in the presence of neural
induction medium (NI, Supplementary Table 3) and maintained in cul-
ture for 1 week to promote early neural differentiation, performing a
total medium change three times a week. Neuroepithelial aggregates,
called rosettes, became visible, already after 48h and on day 8 were
cut in fragments using a 30G needle and p100 μl tip, using a phase con-
trast microscope under sterile conditions. Fragments were partially dis-
sociated using a p1000 tip and 1ml of PBS 1x and were replated on
laminin coated dishes in the presence of neuronal differentiation medi-
um (ND, Supplementary Table 4). Cells were cultured for at least 3 addi-
tional weeks to promote full maturation and differentiation performing
a totalmedium change twice aweek. At day28of differentiation (day 0of
toxicity test), IMR90-derived neuronal cells were exposed to 2-naphthol-
AS-E-phosphate (KG-501, Sigma-Aldrich) up to 14 days, refreshingmedi-
um together with KG-501 treatment every 3–4 days and using DMSO as
solvent control. Samples were collected for analyses at 3 h, 1 day,
3 days, 7 days and 14 days (Supplementary Fig. 5D). To evaluate delayed
cytotoxicity, IMR90-neuronswere treated for 3 h, 1 day, 3 days or 7 days,
then KG-501 was withdrawn and medium was refreshed for additional
14 days, as indicated in Supplementary Fig. 5E.
Quantitative real-time PCR (qPCR) analyses. Analysis of gene expres-
sion by qPCR has been performed on undifferentiated cells, embryoid
bodies, as well as neuroectodermal aggregates as well as in untreated
and KG-501-treated differentiated cells. Cells were resuspended in
100 μl of cold RNA lysis buffer provided within the RNAqueous®-
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manufacturer's instructions and 0.5 μg of total RNA was reverse-
transcribed using High Capacity cDNA Reverse Transcription Kits (as
directed, Applied Biosystems). qPCR reactions were run in duplicate
using TaqMan® Gene Expression Master Mix (Applied Biosystems)
and several TaqMan Gene Expression Assays (Supplementary Table 5).
Fluorescent emission was recorded in real-time (Sequence Detection
System 7000HT, Applied Biosystems). PCR ampliﬁcation conditions
consisted of 40 cycles with primers annealing at 60 °C. Relative RNA
quantities were normalized to GAPDH and β-actin as reference genes
and undifferentiated H9 or IMR90 cells (at day 0), or untreated differen-
tiated H9 or IMR90 cells were used as calibrating conditions (ΔΔCt
Method). Additionally, TaqMan Human Stem Cell Pluripotency Array
(Applied Biosystem, as directed) was used to compare undifferentiated
H9 vs undifferentiated IMR90.
Immunocytochemistry and neurite outgrowth analyses by high content
imaging (HCI). Analyses of pluripotency and neuronal-related
markers were performed by using the Thermo Scientiﬁc Cellomics
ArrayScan vTi for HCI. Brieﬂy, undifferentiated (about 20 colony frag-
ments/well in 96 well plates) and differentiated cells (about 6000
cells/well in 96 well plates) were ﬁxed in cold 4% formaldehyde for
15 min, rinsed with PBS and stored at 4 °C prior to analysis. Staining
for a wide range of primary antibodies was performed (Supplementary
Table 6). After incubation, cells were washed and incubated with
species-speciﬁc secondary antibodies conjugated to Alexa dyes
(Invitrogen). Cell nuclei were counterstained with DAPI dye (0.3 μM,
Sigma-Aldrich) to measure total live (i.e. non-pyknotic nuclei) cell
numbers. Cells incubatedwith appropriate isotypic control antibodies
were analyzed to ensure labeling speciﬁcity. Quality of stainingwas vi-
sualized by epiﬂuorescence (Canon). Images were compiled for ﬁgures
using CorelDRAW Graphics X5 (Corel). Quantiﬁcation of mean ﬂuores-
cence intensity and the relative percentages of cell typeswere calculated
using a speciﬁc ArrayScan algorithm (Cytotoxicity V.4 BioApplication),
which applies a speciﬁc nuclear mask around the DAPI staining,
discarding invalid nuclei (i.e. pyknotic bright nuclei and/or clumps of
cells) and, on thevalid nuclei, a cell body shapemaskdesigned according
to the antibody/antigen staining (O'Brien et al., 2006). Secondary anti-
body incubation alonewas used to determine the intensity level of ﬂuo-
rescent background to be subtracted. Neurite outgrowth was calculated
on β-III-tubulin+ cells using a speciﬁc Thermo Scientiﬁc Cellomics
ArrayScan vTi algorithm (Neurite Outgrowth V.4 BioApplication)
that enables automated plate handling, focusing, cell image acquisi-
tion, analysis and neurite outgrowth quantiﬁcation. As already reported
(Radio, 2012), the Neurite Outgrowth algorithm identiﬁes cell nuclei
stained with DAPI (thick blue mask) and neuronal bodies stained with
β-III-tubulin (thick orangemask) (Supplementary Fig. 2E). The neurites
are then identiﬁed by a red mask and the branch points by a yellow
mask. On the acquired images, the mathematical algorithm automati-
cally measures the number of neurites per neuron, the length of the
neurites (expressed in μm) and the number of branch points per
neurite, which is indicative of neurite complexity level. For further
information on this standardized method the following document
can be consulted: http://www.thermoscientiﬁc.jp/cellomics/docs/
LC01572000_NP_Application_note_Bova.pdf.
Reverse phase protein array (RPPA) assays and analysis. Reverse phase
protein array analysis was performed as previously described (Accordi
et al., 2010). In brief, protein lysates were printed in 4-point dilution
curves in duplicate on nitrocellulose-coated slides (FAST slides;
Whatman Schleicher & Schuell) with the 2470 Arrayer (Aushon
BioSystems). Slides were stained for total protein content (Fast Green
FCF; Sigma-Aldrich), and with 50 validated primary antibodies (Supple-
mentary Table 7) using the Catalyzed Signal Ampliﬁcation System kit
(DAKO). The TIF images of antibody- and Fast Green FCF-stained slideswere analyzed using the Microvigene software (VigeneTech Inc) to ex-
tract numeric intensity values from the array images.Assessment of cell viability with Alamar Blue assay. To get a ﬁrst indi-
cation on the cytotoxic effects of KG-501, neuronal cells were exposed
for 3 h, 1 day, 2 days, 7 days or 14 days to KG-501 at concentrations
ranging from 0.1 to 75 μM, after which cell viability was assessed
using the Alamar Blue (resazurin) assay. To this end, the medium con-
taining KG-501 was removed and cells were incubated with 10 μM
resazurin (diluted in ND medium) keeping the plates for 2 h in the
incubator (37 °C, 5% CO2). Subsequently, the ﬂuorescence of resoruﬁn
was measured at 530–560 nm/590 nm (excitation/emission) in a
multiwell ﬂuorimetric reader (Tecan). The results were normalized to
the mean of untreated cells (control).Gene expression proﬁling of undifferentiated and differentiated PSC
samples. Total RNA was extracted using trizol/chloroform and puri-
ﬁedwith RNeasymini columns as recommended by themanufacturer's
instructions (Qiagen, Hilden, Germany). All reagents and instru-
mentation pertaining to oligonucleotide microarrays were procured
from Affymetrix (Affymetrix, Santa Clara, CA, USA, http://www.
affymetrix.com). Total RNA (100 ng) was used for ampliﬁcation and
in-vitro transcription using the Genechip 3′ IVT Express Kit following
the manufacturer's instructions (Affymetrix). The ampliﬁed RNA was
puriﬁed with magnetic beads and 15 μg of Biotin-RNA was fragmented
with a fragmentation reagent. 12.5 μg of fragmented RNA was hybrid-
ized to Affymetrix Human Genome U133 plus 2.0 arrays along with
hybridization cocktail solution and then placed in Genechip Hybrid-
ization Oven-645 (Affymetrix) rotating at 60 rpm at 45 °C for 16 h.
After incubation arrays were washed on Genechip Fluidics Station-450
(Affymetrix) and stained with Affymetrix HWS kit following the
manufacturer's protocols. The chips were scanned with Affymetrix
Gene-Chip Scanner-3000-7G and the quality control matrices were con-
ﬁrmed with Affymetrix GCOS software following the manufacturer's
guidelines.Determination of signiﬁcantly altered gene proﬁling between undif-
ferentiated and differentiated samples. Robust Multi-array Analy-
sis algorithm (RMA) did background correction, summarization
and normalization. Quantile normalization method (Bolstad et al.,
2003) was employed to normalize the raw dataset at probe feature
level executable with R (Affy)-package (Gautier et al., 2004). Linear
model implementing R-LIMMA packages (Linear Models for micro-
array data) (Smyth, 2004) describes the signiﬁcantly altered gene
proﬁle. For statistical ﬁltration of differentially regulated genes,
cut-off values of 5% error rate (p b 0.05) estimated by moderated
t-statistics with Benjamini and Hochberg Multiple Testing Correc-
tion along with the fold change threshold value ≥ (plus minus)
2.0 were used. K-Mean cluster analysis was performed after
transcript-wise normalization of signal values to a mean of 0 and
standard deviation of 1 using Euclidian distance measurement
and k = 7, using Cluster 3.0 tool from Eisen lab (Eisen et al., 1998).Statistical analysis. Graphs were prepared and statistical analyses
were performed using Graph Pad Prism version 5. All values are pre-
sented as mean ± standard error of the mean (SEM). Statistical sig-
niﬁcance was assessed by one-way ANOVA with Dunnett's multiple
comparisons test or by 2-tailed unpaired or paired t-test according
to the type of analysis. For all graphs, an asterisk (*) over a bar or
over a bracket indicates a signiﬁcant difference (i.e. p b 0.05) with
the control group (i.e. either undifferentiated or untreated cells), un-
less otherwise speciﬁed in the ﬁgure legend.
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Characterization of undifferentiatedH9-hESCs and IMR90-hiPSCs and anal-
ysis of pluripotency
A high level of standardization of undifferentiated cell cultures
as well as of the differentiation process is required in order to ensure
the establishment of robust test systems using PSC-derived cells
(Pistollato et al., 2012). We ﬁrst analyzed the gene expression proﬁle
comparing undifferentiated IMR90-hiPSCs with undifferentiated
H9-hESCs in order to evaluate the similarity of the two PSC types.
Quantitative real time PCR (qPCR) analyses of undifferentiation/
pluripotency related genes, by using the Taqman human pluripotency
array, showed quite similar proﬁles comparing undifferentiated H9
vs IMR90, except for the slightly higher expression of GBX2, LIFR,
NODAL and Xist genes in IMR90 than in H9 (Supplementary Fig. 1A)
(not signiﬁcantly different). In particular, Xist (X-inactive speciﬁc tran-
script) is a major effector of the X inactivation process and its expres-
sion is variable in female undifferentiated hESCs (Shen et al., 2008;
Silva et al., 2008; Lengner et al., 2010) and hiPSCs (Tchieu et al., 2010;
Bruck and Benvenisty, 2011), which may reﬂect some variability in
the epigenetic state and developmental potential of these cell types.
Moreover, undifferentiated H9 and IMR90 cells were stained by the
pluripotency relatedmarkers Oct4, SSEA3 and Tra1-60 (Supplementary
Fig. 1B), while percentages of nestin+ and β-III-tubulin+ cells were low
(Supplementary Fig. 1B). In addition, stem cell pluripotency was ana-
lyzed by “spontaneous” embryoid body (EB) formation, which induces
the formation of the three germ layers (Shamblott et al., 2001). Analyses
of germ layer speciﬁc genes indicated that both H9 and IMR90 cells
underwent a similar increase of endodermal (AFP, KRT18), ectodermal
(Nestin, Sox1 and Pax6) and mesodermal (NPPA and Brachyury-T)
related gene expression (Supplementary Figs. 1C, D). Comparing the
two cell lines, a higher Pax6 and AFP expression was observed in
IMR90-derived EBs than in H9-derived EBs, as compared to their
respective undifferentiated controls (dotted lines, SupplementaryFig. 1.Neuronal differentiation of PSCs. (A) Representative scheme summarizing the described n
of undifferentiated colonies (H9 p35 and IMR90 p40), of EBs at day 1, of rosettes at day 7, with
200 μm) and of neuronal cells at day 25.Figs. 1C, D), which might reﬂect some differences in pluripotency and/
or some diverging differentiation tendencies between the two cell
models.
Characterization of H9-hESC- and IMR90-hiPSC-derived post-mitotic
neurons and glia
A thorough characterization of PSC-derivatives is needed when
aiming to use PSC-derived cultures to assess the effects of pathway
perturbations in relation to neuronal cell injury.
We differentiated H9-hESCs and IMR90-hiPSCs into post-mitotic
neurons, according to our previously described protocol (Stummann
et al., 2009) (Figs. 1A–C and 2A–F). We characterized the differentiated
cultures by performing the following assays: (i) analyses of neuronal
and glia speciﬁc genes and proteins; (ii) analyses of neurite-related
parameters; (iii) characterization of the neuronal subtypes; (iv) whole
gene expression proﬁling followed by the analysis of signaling path-
ways; and (v) analysis of neuronal-related pathways at the protein
level.
By applying our neuronal differentiation protocol (Fig. 1A), rosette-
like structures started to become visible 5–8 days after EB plating in
the presence of neural induction (NI) medium (Figs. 1B, C (rosettes at
day 7)). Importantly, the majority of the cells were nestin+ and β-III-
tubulin+ cells within these structures, indicative of neuronal precursors
and immature neurons, and were localized mainly at the periphery of
the rosettes (colored insets, Figs. 1B, C). Immunostaining and high con-
tent imaging (HCI) on the differentiated cultures (28 days of differenti-
ation) showed a decrease of pluripotency related markers in
differentiated vs undifferentiated cells, together with a decrease in the
number of Ki67+ cells, a well described cell cycle marker (signiﬁcant
only in differentiated IMR90 neuronal cultures) (Supplementary
Fig. 2A). By contrast, an increase of neuronal cells, such as β-III-
tubulin+, MAP2+ and NF200+ cells, occurred upon differentiation in
the two cell models (Figs. 2A–C and F, Supplementary Fig. 2B). More-
over, we detected a modest proportion of neural stem nestin+ cellseuronal differentiation protocol. (B, C) (From the left) Representative phase-bright images
20× magniﬁcation insets showing nestin+ (green) and β-III-tubulin+ cells (red) (bar =
Fig. 2. Both hESC-H9 and hiPSC-IMR90 cells after 28 days differentiate toward neurons and glia. (A–D) Representative immunocytochemical images of β-III-tubulin (Tuj1, red), MAP2
(red), NF200 (green) and GFAP (green) (insets with bar = 100 μm) (H9 p37, IMR90 p42). (E) Bar graph reporting qPCR analyses of indicated genes, all normalized to β-actin and
GAPDH and then calibrated to undifferentiated H9 or IMR90 cells (for both, dotted line) (ΔΔCtmethod). Mean± SEMof 6 independent analyses for IMR90 and of 4 independent analyses
for H9. (F) Bar graph reporting % of indicated cell markers on total live DAPI + cells, mean ± SEM of 5 independent analyses for both cell lines. (G) Bar graph reporting percentages of
different neuronal cell sub-populations on total live DAPI+ cells (mean of 3 independent analyses ± SEM for both cell lines).
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ditionally, we found that H9 and IMR90 differentiated cultures were
also characterized by the presence of about 15–20% of GFAP+ cells, in-
dicative of astroglia (Fig. 2D, F) and 4% of GalC+ cells, indicative of ma-
ture oligodendrocytes (Fig. 2F). Interestingly, by differentiating the two
cell culture types for longer times (i.e. 5–8 weeks) we could not detect
signiﬁcant differences compared to cells differentiated for 4 weeks
(Supplementary Figs. 2C, D).
qPCR analysis on H9 and IMR90 cells undergoing differentiation
showed a similar downregulation of the pluripotency-related genes
Oct4 (POU5F1) and Nanog, starting from day 4 of differentiation (Fig. 2E
and Supplementary Figs. 3A, B). Conversely, the neuroectodermal
related genes Pax6 and Sox1 were upregulated three times more than
the undifferentiated cells up to day 12 of differentiation, reaching a pla-
teau later on during differentiation, while nestin expression did not
change (Supplementary Figs. 3C, D). Furthermore, a marked increase
in the expression levels of the neuronal related genes NCAM1
and MAP2 was observed in both H9 and IMR90-derived neuronal
cells as compared to their undifferentiated counterparts (Fig. 2E
and Supplementary Figs. 3E, F). Additionally, qPCR analyses of
synaptophysin (SYP) and microtubule-associated protein tau
(MAPT), the former expressed at the synaptic level, the latter in
distal portions of axons, revealed an increase of expression upon dif-
ferentiation (Fig. 2E).
By using a speciﬁc HCI algorithm to analyze the number, the length
and the level of complexity of the neurites, based on β-III-tubulin stain-
ing (Supplementary Fig. 2E), we found that H9 and IMR90-derivedneurons formed different types of neurites. IMR90-neurons were char-
acterized by the presence of a higher number of neurites/neurons,
but were shorter and structurally less complex (i.e. with less branch
points), than the ones formed by H9-neurons (Supplementary
Fig. 2F). This might reﬂect some differences between the two cellular
models in the neuronal polarization capability (Yamamoto et al.,
2012).
We sought to better characterize the neuronal subtypes present in
our differentiated cell cultures. Our HCI data showed that both the dif-
ferentiated cell models were characterized by a high percentage of the
two major types of forebrain neurons, glutamatergic (VGlut1+, ~35%
for H9 and ~42% for IMR90) and GABAergic neurons (GABA+, ~6% for
H9 and ~11% for IMR90 and GAD67+, ~22% for H9 and ~25% for
IMR90) (Fig. 2G and Supplementary Figs. 4A, B). Importantly, also a pro-
portion of dopaminergic neurons were present in both differentiated
cell models (TH+, ~13% for H9 and ~20% for IMR90) (Fig. 2G and Sup-
plementary Figs. 4A, B). Cholinergic neurons (ChAT+ cells) were not
represented in both cell cultures. qPCR analyses mainly conﬁrmed HCI
data, indicating that especially dopaminergic, noradrenergic, gluta-
matergic and GABAergic-related genes were upregulated in both H9
and IMR90-derived neuronal cells compared to undifferentiated cells,
together with motor neuron and cholinergic-related genes (Supple-
mentary Fig. 4C). However, some genes (i.e. GABRA1 and LHX3) resulted
differentially expressed comparing differentiated H9 vs differentiated
IMR90 (Supplementary Fig. 4C), indicating a possible difference in tran-
scriptional regulation of the neuronal differentiation process between
the two cell types.
383F. Pistollato et al. / Toxicology and Applied Pharmacology 280 (2014) 378–388Furthermore, we performed a complete gene expression proﬁling
using 3′ IVT gene expression analysis using Affymetrix. By comparing
undifferentiated H9 and IMR90 against their differentiated counter-
parts, we retrieved 7 gene clusters (Supplementary Fig. 5A). Particular-
ly, cluster 1 was representative of 1523 genes/probes that resulted
upregulated upon neuronal differentiation in both the cellular models
(Fig. 3A), cluster 3 comprised 1319 genes/probes that resulted mainly
downregulated upon neuronal differentiation and cluster 4 grouped a
relatively small number (141) of genes/probes that were generally up-
regulated in IMR90 cells, regardless their status (i.e. undifferentiated
and/or differentiated) vs H9 cells (see annexed “Speciﬁc gene clusters
1-3-4” xls ﬁle). By performing a KEGG pathway analysis, using the
DAVID Functional Annotation Bioinformatics Microarray Analysis soft-
ware (http://david.abcc.ncifcrf.gov/), we found that a high number of
the upregulated genes/probes included in cluster 1 (Fig. 3A) were re-
lated to focal adhesion, MAPK signaling, endocytosis, Wnt signaling,
neurotrophin and axon guidance (Fig. 3B); cluster 3 comprised genes
involved in signaling pathways, such as purine metabolism, cell cycle,
pyrimidine metabolism, RNA degradation, metabolism of several
amino acids and tight junction regulation (Supplementary Fig. 5B);
and cluster 4 grouped genes, unrelated to an undifferentiated or aFig. 3.H9 and IMR90-derived neuronal cultures undergo upregulation/activation of neuronal re
probes comprised into cluster 1 (genes upregulated upon differentiation in both cell cultures). A
and differentiated samples). (B) Bar graph reporting KEGG pathway analysis on cluster 1. (C) B
ferentiated samples (for both cell lines, dotted line) using the Microvigene software, following
bars). Analyzed proteins have been clustered together as indicated: Erk/CREB pathway, Notch1
related pathways (mean ± SEM of 4 independent analyses for both the cell models).neuronal phenotype, but related to focal adhesion, regulation of actin
cytoskeleton, gonadotropin-releasing hormone (GnRH) signaling and
leukocyte transendothelial migration (Supplementary Fig. 5C).
Additionally, we sought to evaluate speciﬁcally which neuronal
related signaling pathways were activated at the protein level in the
two cellular models upon neuronal differentiation. Analyses by reverse
phase phosphoproteomic array (RPPA) conﬁrmed the gene expression
data, showing that a speciﬁc neuronal signature was similarly upregu-
lated in both differentiated H9 and IMR90 cells (Fig. 3C). In particular,
among the 50 analyzed proteins (Supplementary Table 7), identiﬁed
by using antibodies speciﬁc for phosphorylated and total protein iso-
forms, we found Erk/CREB, Notch1, Akt/PDK1/mTOR, Shh, Wnt, SAPK/
JNK and Smad-1,5,8 pathway related proteins upregulated/activated
upon differentiation (Fig. 3C).
Effects of exogenous CREB signaling inhibition by 2-naphthol-AS-E-
phosphate (KG-501)
Because of the relevance of the CREB pathway in relation to neuronal
diseases (Saura and Valero, 2011) and neurotoxicity (Schuh et al., 2002;
Chalovich et al., 2006; Damodaran et al., 2009; Zuo et al., 2009; Liu et al.,lated genes and proteins. (A) Heatmap resulting frommicroarray analysis reporting genes/
nalysis is representative of three independent runs for all the conditions (undifferentiated
ar graph reporting absolute protein quantiﬁcations normalized to their respective undif-
RPPA analyses, comparing differentiated H9 (black bars) and differentiated IMR90 (blue
pathway, PDK1/Erk/Akt/mTOR pathway, Shh, Wnt, SAPK/JNK pathways and other neural
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dependent inhibition of CREB signaling in our hiPSC-neuronal model.
To this end, we exposed the hiPSC-derived neuronal cultures up to
14 days to the speciﬁc CREB inhibitor 2-naphthol-AS-E-phosphate
(KG-501) (see treatment scheme in Supplementary Fig. 5D) and we
assessed both CREB signaling pathway- (i) and speciﬁc neuronal-
related endpoints (ii). KG-501 is known to disrupt the CREB:CBP com-
plex and attenuates target gene induction in response to cAMP agonists
(Best et al., 2004) (Fig. 4A).
To get a ﬁrst indication on the cytotoxic effects of KG-501, neuronal
cells were assessed for cell viability using the Alamar Blue (resazurin)
assay performed after 3 h, 1 day, 2 days, 7 days and 14 days of KG-501
treatment, applying KG-501 concentrations ranging from 0.1 to 75 μM
(Fig. 4B). These data show that KG-501 induced a decrease of cellular
resoruﬁn formation (as a surrogate for cell viability) in a time depen-
dent manner. Particularly, we found that KG-501 at the concentration
of 25 μM, which has been reported to almost completely block CREB
downstream gene expression in a reporter gene cell system (Best
et al., 2004), decreased cell survival in IMR90-derived cells after 7-day
exposure, while no effect on cell viability was observed in the short
term (i.e. after 3 h, 1 day and 2 days) (Fig. 4B).
We then assessed the time dependent effects of 25 μMKG-501 (Sup-
plementary Fig. 5D) on some CREB signaling pathway-related end-
points. We ﬁrst analyzed the effects of KG-501 on the relative amount
and the localization of phosphorylated CREB protein (pCREB (S133),
using HCI) as well as the relative expression of selected CREB down-
stream genes (using qPCR) (Figs. 4C, D). Our data indicate that KG-
501 treatment did not evoke an early (i.e. 3 h) effect on pCREB-(S133)
levels, which is in accordance with previous report on forskolin treated
HEK293T cells (Best et al., 2004). However, upon 1 day and 3 days of
KG-501 exposure, we found a higher percentage of pCREB-(S133)+Fig. 4. Effects of KG-501 on CREB-related events in IMR90-derived neuronal cultures. (A) Cartoo
on neuronal survival upon a 3-h, 1-day, 2-day, 7-day and 14-day exposure, measured by the Ala
on cytoplasmic and nuclear pCREB expression levels, analyzed by HCI (C), andmRNA expression
GAPDH and then calibrated to untreated cells (Ctr, dotted line, ΔΔCt method). For B, C and D,
analyses are shown.cells, presenting staining both in the cytoplasm as well as in the nucleus
(Fig. 4D). However, after 14 days of KG-501 treatment pCREB levels re-
sulted comparable to control (Fig. 4C).
Gene expression analyses indicate that 25 μMKG-501 induces differ-
ent effects on the expression of the selected CREB downstream genes
(Fig. 4D). Particularly, BDNF-AS1 (brain derived neurotrophic factor)
expression, which is critical for neuronal survival, morphogenesis and
plasticity (Numakawa et al., 2010), already decreased on day-3 of KG-
501 exposure, whereas no effects were found at earlier time points
(i.e. 3 h and 1 day). Interestingly, the monoamine vesicular transporter
related gene SLC18A1, which allows the transport of biogenic mono-
amines, such as serotonin, from the cytoplasm into the secretory vesi-
cles (Essand et al., 2005), was the most sensitive to KG-501 treatment,
as a decrease was already observed after 3 h (Fig. 4D). Moreover, the
expression of NR4A2 (Nurr1), which is related to dopaminergic neuron
physiology (Sacchetti et al., 2006), was transiently increased at 3 h and
1 day, whereas no effect was found at later time points (i.e. 3 days,
7 days and 14 days) (Fig. 4D). FOS expression, which is indirectly related
to neuronal activity (Dragunow and Faull, 1989; VanElzakker et al.,
2008) (Day et al., 2008), resulted upregulated starting from 1-day expo-
sure (Fig. 4D), while no effect was observed on the expression of
PPARGC1 (PGC1), a regulator of mitochondrial biogenesis and function
(Wu et al., 1999) (Fig. 4D). When analyzing the same CREB-related end-
points on IMR90-derived neurons that have been treated with lower
concentrations of KG-501 (i.e. 1.2 and 6 μM) for 3 h, 1 day, 3 days,
7 days or 14 days, no signiﬁcant changes in CREB-related gene expres-
sion were observed (see 6 μM KG-501 treatment in Supplementary
Fig. 6A).
In order to evaluatewhether KG-501-induced inhibition of CREB sig-
naling resulted in detectable neuronal cell injury in IMR90-derived neu-
ronal cultures we assessed the effects of a 3-h, 1-day, 3-day, 7-day andn summarizing KG-501's effect at themolecular level. (B) Concentration-dependent effect
mar Blue assay. (C, D) Analysis on the effect of a time-dependent 25 μMKG-501 exposure
levels of selected CREB related genes (D). Gene expressionwas normalized to β-actin and
values were normalized to untreated cells (Ctr). For all the analyses, mean ± SEM of 3–4
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the fraction of β-III-tubulin+,MAP2+, NF200+ andGFAP+ cells (Figs. 5B
and D, upper panels), neurite outgrowth, neurite length, the number of
neurites per neuron and the number of branch points per neurite
(Figs. 5C and D, lower panels), all measured by HCI, and the expression
of synaptogenesis-related genes (Fig. 5E). In accordance to the viability
test (Fig. 4B), we found a signiﬁcant reduction of total live cell numbers
starting from 7-day exposure to 25 μMKG-501 (Fig. 5A). Additionally, a
remarked decrease of MAP2+ neuronal cells was already observed after
3 days of KG-501 exposure (Figs. 5B and D, upper panels). The numbers
of β-III-tubulin+, NF200+ and GFAP+ cells did not show signiﬁcant
changes upon KG-501 exposure (Fig. 5B). Moreover, KG-501 induced
a decrease in neurite length, number of neurites/neuron and number
of branch points/neurite, which were already affected at early time
points (i.e. 3 h and day 1) (Figs. 5C and D, lower panels). Moreover, a
signiﬁcant decrease of synaptophysin (SYP, expressed at the synaptic
level) occurred on day-3 of KG-501 exposure, while a decrease of
microtubule-associated protein tau (MAPT, expressed in distal portions
of axons), which is indicative of synapses/synaptogenesis reduction,
was visible after 7 days (Fig. 5E).
Assesswhether the early effects (i.e. at 3 h, 1 day and 3 days) elicited
by 25 μMKG-501were possibly preceding delayed cytotoxicity, we per-
formed “washout” experiments as depicted in Supplementary Fig. 5E. A
single 3 h, 1 day or 3 day exposure to 25 μM KG-501, followed by KG-
501withdrawal andmedium refreshment for 14 days (i.e. same “wash-
out” period for all the time points), did not result in decrease of cell vi-
ability, as shown by quantitation of total live cell numbers (i.e. non-
pyknotic nuclei, Supplementary Fig. 5F). When IMR90-neurons were
exposed for 7 days to 25 μM KG-501, the cell number at day 21 (i.e.
after the 14 day washout period) was similar to the one recorded at
day 7 (Supplementary Fig. 5F, Fig. 5A), indicating no further delayed ef-
fects on cell viability at day 21. These data indicate that the observed
early effects (i.e. the reduction of BDNF-AS1 and SLC18A1 gene expres-
sion, Fig. 4E, and the decrease of MAP2+ cells and neurites, Figs. 5B–D),
should be attributed to a perturbation of CREB signaling induced by
25 μM KG-501 under non-cytotoxic conditions. Moreover, the 7 day
exposure to 25 μMKG-501 (i.e. a prolonged perturbation of CREB signal-
ing) seems to irreversibly impact neuronal cell viability.
Finally, 6 μM KG-501 treatment did not produce any signiﬁcant
change of selected neuronal endpoints at the same exposure times
(Supplementary Figs. 6B–E).
In summary, the data on the effects of KG-501 in our hiPSC-
derived neurons indicate that perturbation of the CREB signaling
pathway early impacts neurite outgrowth and neuronal complexity,
causes a decrease of MAP2+ cells and of synaptogenesis-related gene
expression in the medium term (i.e. after 3 days), and in the long term
(i.e. after 7 days), a decrease of total cell number and cell survival
occurs.
Discussion
In the present studywe describe a robust and relatively rapid proto-
col for the differentiation of hiPSCs (IMR90-hiPSCs) into heterogeneous
cultures of post-mitotic neurons and glia, comparing the differentiation
potential of these cells to hESCs (H9), with the aim to investigate, in the
hiPSC neuronal model, the time-dependent (adverse) cellular effects
elicited by inhibition of the CREB signaling pathway using the speciﬁc
CREB inhibitor KG-501. The obtained data may be useful in the under-
standing of how chemical-induced CREB inhibition relates to neuronal
cell injury. Moreover, this model may be further applied to assess
whether perturbation of the CREB pathway may be relevant to screen
for neurotoxicants, and as such, qualify CREB pathway inhibition as a
toxicity pathway.
In order to screen chemicals for the perturbation of pathways, sig-
naling-reporter gene assays, as used in the TOXCAST program, may be
useful tools. However, these assays do not give insight whether thepossible observed pathway perturbations lead to cell injury. Therefore,
in order to predict toxic cellular outcomes, it is important to assess the
relation of pathway perturbation to toxic effects in speciﬁc cell types.
Also, it may be relevant to predict whether the perturbation of a given
pathwaywill result in (adverse) effects in cells of speciﬁc tissues/organs
and, in this regard, heterogeneous cell derivatives, such as our hiPSC-
derived neuronal cultures, rather than homogenous cell cultures,
might better mimic possible toxicological responses in human tissues
in vivo.
Currently, the use of PSC-derived, and particularly, of hiPSC-derived
cells for regulatory toxicity testing has been taken into great consider-
ation (Kumar et al., 2012), given the capability of hiPSCs to generate
disparate toxicologically relevant cell types, avoiding the diverse na-
tional legislative policies regulating the use of hESC-derived models
and the possible low scientiﬁc reliability related to the use of animal
and cancer-derived cell lines. Deﬁning reproducible differentiation pro-
tocols, yielding heterogeneous cultures of toxicologically relevant cell
types, including progenitor/transit amplifying cells and terminally
differentiated cells is needed to predict physiological in vivo cellular
responses (Trosko and Chang, 2010). In this regard, the detection/
permanence of a modest proportion of neural stem nestin+ cells in
our differentiated cell cultures (Fig. 2F) indicates that the models
might be used to assess whether chemicals may particularly target the
neural stem cell population in neuronal tissues, which is considered
the cell fraction mostly affected by chemically induced mutations or
viral infections (Canovas-Jorda et al., 2014), also according to the cancer
stem cell theory (Sell, 2010). We show that both types of PSC models
can be differentiated into heterogeneous cultures of GABAergic, gluta-
matergic and dopaminergic neurons, together with glial cells. Impor-
tantly, glial cells are fundamental for myelin formation, for the
physiological functionality of neuronal networks and for neuronal ho-
meostasis (Ghosh et al., 2011). Additionally, both PSC-derivatives are
characterized by a similar neuronal signature, with some critical neuro-
nal related signaling pathways upregulated and activated upon differ-
entiation. The relatively small differences we observed between H9
and IMR90-derivatives, such as the diverse neurite proﬁling (Supple-
mentary Fig. 2F), are not necessarily due to the fact of being natural
ESCs or artiﬁcial iPSCs, respectively. Indeed, also hESC lines of different
origins have been shown to vary in their differentiation propensity
using the same differentiation protocol (Osafune et al., 2008).
Among the neuronal pathways that resulted upregulated/activated
in both the differentiated cell models, the CREB pathway is of high rel-
evance for several reasons. CREB plays a central role in the development
and in the physiology of the CNS (Shaywitz and Greenberg, 1999; Lonze
and Ginty, 2002) and has been reported to be affected by several
toxicants, such as diisopropylphosphoroﬂuoridate (Damodaran et al.,
2009), chlorpyrifos (Schuh et al., 2002), 6-hydroxydopamine
(Chalovich et al., 2006), non-dioxin-like polychlorinated biphenyls
(Brunelli et al., 2012), perﬂuorooctane sulfonate (Liu et al., 2010), tribu-
tyltin and trimethyltin (Zuo et al., 2009). This indicates that the pertur-
bation of the CREB pathway may play a role in chemical-induced
neurotoxicity, and as such CREB might represent a relevant toxicity
pathway for neurotoxicants.
To study the relevance of the CREB pathway as a possible neurotox-
icity pathway we assessed the time-dependent molecular and cellular
effects elicited by the speciﬁc CREB inhibitor KG-501 in our hiPSC-
derived neuronal cultures. Upon KG-501 treatment, hiPSC-neurons
activated pro-survival and/or stress-related responses, characterized
by the immediate upregulation of NR4A2 and the downregulation of
SLC18A1 gene expression, occurring within 3 h, together with an
impairment of neurite length and neurite complexity. A transient acti-
vation of CREB and upregulation of FOS gene occurred within 1 day of
KG-501 exposure (early effects). We also measured a progressive loss
of neuronal functionality and survival, as shown by the time dependent
downregulation of BDNF-AS1 and SYP expression and the decrease of
the number of neurites and of MAP2+ neuronal cells, occurring after
Fig. 5. Effects of KG-501 on selected endpoints in IMR90-derived neuronal cultures. (A–D)Analysis on the effect of a time-dependent 25 μMKG-501 exposure on total live cell number
(i.e. non-pyknotic nuclei) (A), relative number of β-III-tubulin+, MAP2+, NF200+ and GFAP+ cells (B), neurite length, neurites/neuron and branch points/neurite (C) and representative
immunocytochemical images ofMAP2+ cells (red, upper panels) and of neurites (black andwhite,β-III-tubulin stained cells, lower panels) comparing untreated cells (Ctr) and cells treat-
ed for 3 days and 7 dayswith 25 μMKG-501 (IMR90 p50) (D). (E) Effect of a time-dependent 25 μMKG-501 exposure on the expression of synaptogenesis-related genes (SYP andMAPT).
Gene expressionwas normalized toβ-actin andGAPDHand then calibrated to untreated cells (Ctr, dotted line,ΔΔCtmethod). For A–C, valueswere normalized to untreated cells (Ctr). For
all the analyses, mean ± SEM of 3 analyses are shown.
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followed by induction of cytotoxicity in the longer term (i.e. after
7 days), as shown by the overall reduction of cell viability (late effects)
(Fig. 6). Notably, the early upregulation of both NR4A2 and FOS genes,
might be related to the activation of pro-survival and/or stress response
mechanismswithin the cells, which could be a result of the inhibition of
CREB. The upregulation of these genes has been reported in other stud-
ies describing the activation of NR4A2-Nurr1 in relation to oxidative
stress (Sousa et al., 2007) and the upregulation of FOS caused by
intermittent hypoxia (Nanduri and Nanduri, 2007) and by stimulant/
anxiogenic drugs (Graybiel et al., 1990; Singewald et al., 2003). It should
also be considered that the upregulation of these CREB-regulated genes
upon KG-501 stimulation might also be evoked by CREB-independent
mechanisms.
Importantly, the changes occurring within the ﬁrst 3 days of expo-
sure (i.e. reduction of BDNF-AS1 and SLC18A1 gene expression, de-
crease of MAP2+ cells and neurite-related measures) seem to be
speciﬁc neuronal effects rather than preceding events of cytotoxicity,
sincewe found that these exposures did neither showacute nor delayed
effects on cell viability.
Altogether these data indicate that KG-501-induced inhibition of the
CREB pathway can be related to cellular endpoints in our hiPSC-derivedneuronal cultures which may be relevant for studying neurotoxicity.
Among the analyzed endpoints, effects on neurite length and complex-
ity and the reduction of MAP2+ cell number showed to be the most
sensitive and may represent relevant endpoints for neurotoxicity test-
ing in vitro. Furthermore, considering the persistent downregulation
of SLC18A1 and the time-dependent decrease of BDNF-AS1 expression,
we hypothesize that SLC18A1 and BDNF-AS1 genes might represent
sensitive markers to predict neurotoxic effects in vitro in relation to
perturbations of the CREB pathway.
To further develop our test system and increase our understanding
of the possible relation between CREB perturbation and chemical-
induced cellular injury, the model should be challenged with a set of
selected neurotoxic compounds. These follow-up studies should give
insight on how often the CREB pathway is perturbed when the cells
are exposed to neurotoxicants of diverse nature in order to assess the
prevalence of CREB pathway perturbations for neurotoxicants and to
assess whether measuring CREB pathway perturbations is useful for
theprediction of neuronal cell injury. These studiesmayprovide speciﬁc
biomarkers related to pathway disturbance that can be measured at
selected time points in order to predict whether new unknown com-
pounds may cause neuronal cell injury. Moreover, further experiments
with KG-501 and selected chemicals using neuronal cell cultures
387F. Pistollato et al. / Toxicology and Applied Pharmacology 280 (2014) 378–388derived from different hiPSC lines should be performed in order to
assess possible inter-individual differences in toxicodynamics related
to CREB pathway inhibition.
The hiPSC-basedmodel may also be useful in activities related to the
recently initiated adverse outcomepathway (AOP)-concept. An AOP is a
conceptual framework that describes existing knowledge concerning
the linkage between a molecular initiating event (MIE) and an adverse
outcome (AO) that occurs at a level of biological organization relevant
to risk assessment (Vinken, 2013). It consists of the description of key
events that lead from the MIE to the AO (Vinken, 2013). At present, no
AOP has been described in which perturbation of CREB signaling rep-
resents a key event in the AOP. Our cell model may be useful in the
elucidation of a CREB-related AOP, and/or may be a relevant tool to
measure effects on CREB signaling when AOPs would be developed
that include CREB signaling perturbation as a key event.
The data on CREB signaling inhibition here presented indicate that
this model can be used to study the relation of chemical-induced
CREB pathway perturbation to chemical-induced (adverse) cellular ef-
fects. Further studies with well-known neurotoxicants may indicate
whether perturbation of the CREB pathway may be relevant to screen
for neurotoxicants, and as such qualify CREB pathway perturbation as
a toxicity pathway.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.taap.2014.08.007.
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